Adler Reid G.'s most recent trade in VistaGen Therapeutics Inc was a trade of 7,541 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on June 30, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
VistaGen Therapeutics Inc | Reid G. Adler | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 1.70 per share. | 30 Jun 2025 | 7,541 | 24,050 (0%) | 0% | 1.7 | 12,820 | Common Stock |
VistaGen Therapeutics Inc | Reid G. Adler | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
VistaGen Therapeutics Inc | Reid G. Adler | CHF CORP DEVEL OFF, GEN COUNS | Grant, award, or other acquisition of securities at price $ 2.96 per share. | 28 Jun 2024 | 4,854 | 16,509 (0%) | 0% | 3.0 | 14,358 | Common Stock |
VistaGen Therapeutics Inc | Reid G. Adler | CHF CORP DEVEL OFF, GEN COUNS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
VistaGen Therapeutics Inc | Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | Grant, award, or other acquisition of securities at price $ 1.72 per share. | 29 Dec 2023 | 167 | 11,655 (0%) | 0% | 1.7 | 287 | Common Stock |
VistaGen Therapeutics Inc | Reid G. Adler | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 1.59 per share. | 30 Jun 2023 | 167 | 11,488 (0%) | 0% | 1.6 | 265 | Common Stock |
VistaGen Therapeutics Inc | Reid G. Adler | CHIEF LEGAL OFFICER | Purchase of securities on an exchange or from another person at price $ 0.17 per share. | 17 Aug 2022 | 300,000 | 334,629 (0%) | 0% | 0.2 | 50,910 | Common Stock |
VistaGen Therapeutics Inc | Reid G. Adler | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 200,000 | 200,000 | - | - | Stock Options (right to buy) |